2018 annual financial data
REGENXBIO 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was 47.89%.
Operating income was 88,100,000 USD and net income was 99,937,000 USD.
Operating cash flow was 104,648,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 218,505,000 USD
- Operating income
- 88,100,000 USD
- Net income
- 99,937,000 USD
- Operating cash flow
- 104,648,000 USD